Elizabeth Forminard
Known title: Executive VP, General CounselCIK: 0001950802
Associated companies
Transaction History
| JNJ | ▼ Sell | Open Market | 9,344 | $2.4M | 8/6/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 9,344 | $1.2M | 8/6/2026 | View on chart |
| JNJ | ▼ Sell | Open Market | 6,574 | $1.7M | 8/6/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 961 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 492 | $120K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,063 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 544 | $132K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 651 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 314 | $77K | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 13,706 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 7,011 | $1.7M | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 8,921 | $1.2M | 2/5/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 6,226 | $1.5M | 2/5/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 11,521 | $1.3M | 8/29/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 9,570 | $1.7M | 8/29/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 307 | $48K | 2/18/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 961 | $0 | 2/15/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,352 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 464 | $73K | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 215 | $33K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 851 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 267 | $42K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 651 | $0 | 2/13/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 651 | $0 | 2/13/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 236 | $37K | 2/13/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 2,448 | $0 | 2/12/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 411 | $0 | 2/12/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 1,034 | $163K | 2/12/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 979 | $0 | 2/8/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 363 | $57K | 2/8/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 924 | $150K | 2/13/2023 | View on chart |
| JNJ | ▲ Buy | Grant | 2,555 | $0 | 2/13/2023 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,022 | $0 | 2/10/2023 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 380 | $62K | 2/10/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Johnson & Johnson: Key Takeaways for Long-Term Investors
Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.
Johnson & Johnson: Key Takeaways for Long-Term Investors. Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.